My wife works for big Pharma, pretty high up the chain regarding trials. She told me to buy this when it was in the high 20's and I didn't and watched it go all the way to 80's.
The crazy selloff was stupid... She like Portolo also. Many big Pharma are using abixiban and this could be a buyout as well...
ESPR is in a crowded space, but the first Esperion was bought by Pfizer and this one could be bought by big pharma as well
Market Data 
Markets 
AI
